The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PROfound: A randomized Phase III trial evaluating olaparib in patients with metastatic castration-resistant prostate cancer and a deleterious homologous recombination DNA repair aberration.
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); PARP inhibitors and DNA repair defects (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex
 
Maha Hussain
Consulting or Advisory Role - Abbvie; Bayer; Genentech/Roche
Research Funding - Genentech (Inst); PCCTC (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - TITLE: Dual Inhibition of MET and VEGF for the treatment of castration resistant prostate cancer and osteoblastic bone metastases. Applicant/Proprietor Exelexis, Inc. Application No/Patent No. 11764665.4- 1464 Application No/Pat; TITLE: METHOD OF TREATING CANCER Docket No: Serial Number: 224990/10-016P2/311733 61/481/671 Application Filed on: 5/2/2011; TITLE: SYSTEMS AND METHODS FOR TISSUE IMAGING, 3676 Our File: Serial Number: UM-14437/US-1/PRO 60/923,385 UM-14437/US-2/ORD 12/101,753
Travel, Accommodations, Expenses - Abbvie; Bayer; Genentech
 
Antoine Thiery-Vuillemin
Employment - AstraZeneca
Honoraria - Johnson & Johnson; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Novartis; Roche
Research Funding - Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Joaquin Mateo
Travel, Accommodations, Expenses - AstraZeneca; Sanofi
 
A. Oliver Sartor
Consulting or Advisory Role - AstraZeneca (Inst); Bayer; Bellicum Pharmaceuticals; Dendreon; Johnson & Johnson; Medivation; Oncogenex; Progenics (Inst); Sanofi; Tokai Pharmaceuticals
Research Funding - Bayer (Inst); Dendreon (Inst); Endocyte (Inst); Innocrin Pharma (Inst); Johnson & Johnson (Inst); Progenics (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bellicum Pharmaceuticals; Johnson & Johnson; Medivation; Oncogenex; Progenics; Sanofi; Tokai Pharmaceuticals
 
Kim N. Chi
Honoraria - Amgen; Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi; Takeda
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Lilly/ImClone (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst)
 
Karim Fizazi
Honoraria - Amgen; Astellas Pharma; Janssen; Merck; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Curevac; ESSA; Janssen Oncology; Orion; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Amgen
 
Przemyslaw Twardowski
Stock and Other Ownership Interests - Exelixis
Honoraria - Astellas Pharma; Janssen
Consulting or Advisory Role - Roche/Genentech
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Roche/Genentech
 
Neeraj Agarwal
Consulting or Advisory Role - Argos Therapeutics; Cerulean Pharma; Eisai; EMD Serono; Exelixis; Medivation/Astellas; Merck; Novartis; Pfizer
Research Funding - Amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Shahneen Kaur Sandhu
Honoraria - Amgen; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Amgen
Speakers' Bureau - Bristol-Myers Squibb; Merck
 
David Olmos
Other Relationship - AstraZeneca
 
Neal D. Shore
Consulting or Advisory Role - Bayer; Dendreon; Ferring; Janssen Scientific Affairs; Medivation/Astellas; Sanofi; Takeda; Tolmar
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Janssen Oncology; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Sherry Liu
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Carsten Dietrich Goessl
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Joe Burgents
Employment - AstraZeneca; Bavarian Nordic; Merrimack (I); NewLink Genetics (I)
Stock and Other Ownership Interests - AstraZeneca